Treatment of depression in adolescents with mild to moderate learning disability Mental and Behavioural Disorders
Conditions
Interventions
This trial will be a single-centre, single-blind, two-armed feasibility RCT (RCT) of Beat-D delivered in special education settings, compared to support as usual (SAU). Beat-D (treatment) is a structu
Sponsors
University of Warwick
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adolescents with a mild to moderate intellectual disability, defined by a score of 70 or below on standardised assessments and deficits in adaptive functioning, and/or administratively defined as having an intellectual disability, for example, enrolled in a special school for children/adolescents with mild intellectual disability 2. Adolescents with the capacity to assent/consent to take part in the research (and therefore would have sufficient communication and understanding to take part in the treatment) 3. Aged 12-17 years 4. Clinically significant unipolar depression as determined using information gathered through clinical interview (Anxiety Disorder Interview Schedule for Children) 5. Has support from a family member or paid carer who can support them throughout the treatment 6. If on medication for depressive symptoms, have been on a stable dose for 4 weeks prior to commencement of intervention
Exclusion criteria
Exclusion criteria: 1. A suicide attempt in the past 6 months 2. Intensive inpatient treatment for mental illness in the past 6 months 3. Factors that prevent the young person from interacting with the supporter and therapist or retaining information from the therapy (for example, severe psychosis, degenerative condition) 4. Currently receiving any psychological therapy for a mental health problem 5. Insufficient English language skills to complete the measures or participate in the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in depressive symptoms measured using the self-reported Glasgow Depression Scale for People with Intellectual Disability (GDS) at baseline and 4 months post-randomisation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in depressive symptoms measured using the Glasgow Depression Scale for People with Intellectual Disability Carer Supplement (GDS-CS). The GDS-CS will be completed by parents/carers at baseline and at 4 months post-randomisation. 2. Behavioural activation and functional engagement with activities measured using the Behavioural Activation for Depression Scale: Short Form (BADS), adapted for adolescents with intellectual disability at baseline and at 4 months post-randomisation 3. Change in anxiety symptoms measured using the self-report Glasgow Anxiety Scale for People with Intellectual Disability (GAS) at baseline and 4 months post-randomisation 4. Change in anxiety symptoms measured using the Spence Children's Anxiety Scale (Spence; parent/carer report) at baseline and at 4 months post-randomisation. 5. Carer self-efficacy measured using the Emotional Difficulties Self-Efficacy Scale (EDSE). The EDSE will be completed by parents/carers at baseline and 4 months post-randomisation. 6. Change in quality of life measured using the EQ-5D-Y self-report version at baseline and 4 months post-randomisation 7. Change in quality of life measured using the EQ-5D-Y proxy (parent) version at baseline and 4 months post-randomisation | — |
Countries
England, United Kingdom
Contacts
Public ContactAndreas Paris
Outcome results
None listed